Urokinase-Type Plasminogen Activator Receptor (CD87) Is a Ligand for Integrins and Mediates Cell-Cell Interaction

Journal of Biological Chemistry - United States
doi 10.1074/jbc.m008220200
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

Ligand Binding Regions in the Receptor for Urokinase-Type Plasminogen Activator

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Requirement of Receptor-Bound Urokinase-Type Plasminogen Activator for Integrin Αvβ5-Directed Cell Migration

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1996English

Soluble Urokinase-Type Plasminogen Activator Receptor Inhibits Cancer Cell Growth and Invasion by Direct Urokinase-Independent Effects on Cell Signaling

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

Urokinase Type Plasminogen Activator Receptor Expression in Colorectal Neoplasms

Gut
Gastroenterology
1998English

Comment on “HAX1 Augments Cell Proliferation, Migration, Adhesion, and Invasion Induced by Urokinase-Type Plasminogen Activator Receptor”

Journal of Oncology
Oncology
2013English

Interaction of Single-Chain Urokinase and Plasminogen Activator Inhibitor Type 1

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Soluble Urokinase-Type Plasminogen Activator Receptor Is a Novel Biomarker Predicting Acute Exacerbation in COPD

2015English

Soluble Urokinase-Type Plasminogen Activator Receptor Is a Novel Biomarker Predicting Acute Exacerbation in COPD

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2015English

Plasminogen Activator Urokinase Receptor (PLAUR; uPAR; suPAR)

Science-Business eXchange
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy